In 2013, 108Labs pioneered mammary cell agriculture
In 2019, 108Labs invented the science behind Biomilq.
In 2020, 108Labs created Colostrupedics™
whole-human infant formula with secretory IgA
In 2021, 108Labs licensed mammary cell derived
drugs & biologicals to
NeutraSiga Therapeutics, Inc
108Labs partnered with NeutraSiga to create personalized antibody therapeutics
108Labs continues R&D to feed and heal with Cellufacturing® innovations
Help us create the future
of food and medicine
108Labs is looking for adventurous scientists to explore cellular agriculture and drug development to create a future where conscious life is not sacrificed for sustenance, Cellufacturing® eliminates the outsized impact of animal agriculture on climate change, and all humans from their first moments to their last are less at risk of losing time to preventable death from infectious disease.